Adia Nutrition (ADIA) Liabilities and Shareholders Equity (2024 - 2026)
Adia Nutrition's (ADIA) quarterly Liabilities and Shareholders Equity came in at $776868.0 in Q1 2026, up 30.6% quarter-over-quarter from $594826.0 in Q4 2025.
Analysis
Adia Nutrition (ADIA) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends
Adia Nutrition (ADIA) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $776868.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity changed N/A year-over-year to $776868.0 in Q1 2026; TTM through Jun 2026 was $1.4 million, a N/A change from a year earlier, with the FY2025 full-year figure at $594826.0, down 10.71% from the prior year.
- Liabilities and Shareholders Equity was $776868.0 for Q1 2026 at Adia Nutrition, up from $594826.0 in the prior quarter.
- Over five years, Liabilities and Shareholders Equity peaked at $776868.0 in Q1 2026 and troughed at $594826.0 in Q4 2025.
- A 3-year average of $679291.7 and a median of $666181.0 in 2024 frame the typical range for Liabilities and Shareholders Equity.
- The widest YoY moves for Liabilities and Shareholders Equity: up 10.71% in 2025, down 10.71% in 2025.
- Over 3 years, Liabilities and Shareholders Equity stood at $666181.0 in 2024, then dropped by 10.71% to $594826.0 in 2025, then surged by 30.6% to $776868.0 in 2026.
- The last three Liabilities and Shareholders Equity figures came in at $776868.0 (Q1 2026), $594826.0 (Q4 2025), and $666181.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn | 1.50 Bn |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - | 2.65 Bn |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn | 915.53 Mn |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn | 1.75 Bn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 985.10 Mn |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn | 170.30 Mn |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - | 1.39 Bn |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn | 3.19 Bn |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | 502.87 Mn |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 776,868.00 |
| Dec 31, 2025 | 594,826.00 |
| Dec 31, 2024 | 666,181.00 |